ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RMD Resmed Inc

32.96
-0.04 (-0.12%)
03 May 2024 - Closed
Delayed by 20 minutes
Share Name Share Symbol Market Type
Resmed Inc ASX:RMD Australian Stock Exchange Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.04 -0.12% 32.96 32.90 33.00 33.27 32.84 33.08 2,135,770 07:20:01

ResMed Announces Participation in the 39th Annual William Blair Growth Stock Conference

23/05/2019 9:05pm

Business Wire


Resmed (ASX:RMD)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Resmed Charts.

ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.m. (Central Time) at the Loews Chicago Hotel in Chicago.

More information about this event, including a live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible for approximately 90 days following the conference.

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.

For investorsAmy Wakeham+1 858-836-5000investorrelations@resmed.com

For mediaJayme Rubenstein+1 858-836-6798news@resmed.com

1 Year Resmed Chart

1 Year Resmed Chart

1 Month Resmed Chart

1 Month Resmed Chart

Your Recent History

Delayed Upgrade Clock